Distinct retinal vessel atrophy patterns may be associated with multiple sclerosis (MS), but further research is needed to assess retinal vessel changes and their underlying role in MS. Changes in the ...
Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...
In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...
A recent retrospective cross-sectional observational study concluded that the Medios AI system, in conjunction with the Remidio smartphone-based fundus camera, has strong potential to ...
Please provide your email address to receive an email when new articles are posted on . Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal ...
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Astellas; Alimera Sciences, Inc.; Ocular Therapeutix, Inc.; Outlook Therapeutics; and REGENXBIO ...
Regardless of dosing regimen, patients treated with ranibizumab had a 43% higher incidence of GA, which was a statistically significant increase compared with bevacizumab. The ranibizumab group had ...
The new DNA test means there is no reason why another English Shepherd Dog ever needs to be born with progressive retinal atrophy, which causes total blindness. Progressive retinal atrophy (PRA) is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results